SOPHiA GENETICS CPO Manuela Valente Exercises Options and Sells Shares

What Happened

• Manuela Valente, Chief People Officer of SOPHiA GENETICS (SOPH), executed option transactions and an open‑market sale on 2026-08-19. She exercised 10,000 options at $3.20 per share (cost $32,000) and sold 10,000 shares in the open market for a weighted average price of $7.94, generating $79,439 in proceeds. A separate line shows 10,000 derivative shares reported as disposed at $0.00 (reported as a derivative disposition).

Key Details

• Transaction date: 2026-08-19; Form 4 filed 2026-08-21 (within the typical filing window).
• Exercise: 10,000 shares exercised at $3.20 (total $32,000).
• Sale: 10,000 shares sold, weighted avg price $7.94, total proceeds $79,439. Reported sale prices ranged from $7.90 to $8.01 (footnote F2).
• Derivative disposal: 10,000 shares reported disposed at $0.00 (listed as a derivative transaction).
• Remaining derivative holdings: After these transactions, Valente holds an aggregate 554,276 derivative share options across remaining grants (footnote F4); the options are fully vested and exercisable (F3).
• Plan note: The sale was made under a pre‑arranged Rule 10b5‑1 trading plan (footnote F1).
• Weighted average detail: The filer can provide the exact number of shares sold at each price within the $7.90–$8.01 range upon request (F2).

Context

• This was an option exercise followed by an open‑market sale. The net pattern—exercise plus a contemporaneous sale—is common and can reflect routine liquidity or planned disposition rather than an ad hoc trading decision.
• The 0.00 disposal line likely reflects a net settlement or shares surrendered (e.g., for tax withholding), which is commonly reported as a derivative disposal; the filing lists no proceeds for that line.
• Because the sale was executed under a 10b5‑1 plan, it was pre‑arranged, which reduces the signaling value of the sale for investors.